Latest News and Press Releases

Aztiq sells Adalvo, one of the leading business-to-business pharmaceutical companies in Europe founded in 2018, to EQT, a global investment organization.

Alvotech has appointed Linda Jónsdóttir as its new Chief Financial Officer.

Alvotech acquires capability and added flexibility in assembly and packaging with acquisition of Ivers-Lee Group

REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) --  Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for...

Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...

TILKYNNING ÞESSI OG UPPLÝSINGARNAR SEM HÉR KOMA FRAM ERU EKKI TIL BIRTINGAR EÐA DREIFINGAR, HVORKI MEÐ BEINUM NÉ ÓBEINUM HÆTTI, Í HEILD EÐA AÐ HLUTA, Í, TIL EÐA FRÁ BANDARÍKJUM NORÐUR-AMERÍKU,...

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH...

REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA...